Skip to main content
SpringerLink
Log in

Should we really compare absolute risk reduction in different trials on osteoporosis: comment on the article by Ringe JD and Doherty JG

  • Letter to the Editor
  • Published:
Rheumatology International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ringe JD, Doherty JG (2009) Absolute risk reduction in osteoporosis: assessing treatment efficacy by number needed to treat. Rheumatology International, published online 25 Dec 2009, doi:10.1007/s00296-009-1311-y

  2. Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, Cannata J, Dalogh A, Lemmel E, Nielsen S, Rizzoli R, Genant HK, Reginster J (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459–468

    Article  PubMed  CAS  Google Scholar 

  3. Chesnut CH, Skag A, Christiansen C, Recker R, Stakkestad JA, Hoiseth A, Felsenberg D, Huss H, Gibride J, Schimmer RC, Delmas PD (2004) Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res 19:1241–1249

    Article  CAS  Google Scholar 

  4. Campbel MJ, Machin D (2003) Medical statistics a commonsense approach, pp 62–63

  5. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385–397

    Article  PubMed  CAS  Google Scholar 

  6. Reginster JY, Seeman E, Vernejoul MC, Adami S, Compston J, Phenekos C, Devogelaer JP, Curiel MD, Sawicki A, Goemaere S, Sorensen OH, Felsenberg D, Meunier PJ (2005) Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: treatment of peripheral osteoporosis (TROPOS) study. J Clin Endocrinol Metab 90:2816–2822

    Article  PubMed  CAS  Google Scholar 

  7. Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC et al (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809–1822

    Article  PubMed  CAS  Google Scholar 

  8. O’Donnel S, Cranney A, Wells GA, Adachi J, Reginster JY (2008) Strontium ranelate for preventing and treating osteoporosis. The Cochrane Library, Issue 4

  9. Wilkes MM, Navickis RJ, Chan WW, Lewiecki EM (2010) Bisphosphonates and osteoporotic fractures: a cross-design synthesis of results among compliant/persistent postmenopausal women in clinical practice versus randomized controlled trials. J Osteoporos Int 21:679–688

    Article  CAS  Google Scholar 

  10. O’Donnell S, Moher D, Kelli Thomas K, Hanley DA, Cranney A (2008) Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls. J Bone Miner Metab 26:531–542

    Article  PubMed  Google Scholar 

  11. Cummings SR, Martin JS, McClung MR, Siris ES, Eastell R, Reid IR, Pierre Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C (2009) For the Freedom trial: denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756–765

    Article  PubMed  CAS  Google Scholar 

  12. Recker RR, Marin F, Ish-Shalom S, Moricke R, Hawkins F, Kapetanos G, de la Pena MP, Kekow J, Farrerons J, Sanz B, Oertel H, Stepan J (2009) Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis. J Bone Miner Res 24:1358–1368

    Article  PubMed  CAS  Google Scholar 

  13. Blake CB, Compston JE, Fogelman I (2009) Could strontium ranelate have a synergistic role in the treatment of osteoporosis? J Bone Miner Res 24. Published online on 15 June. doi:10.1359/JBMR.090601

  14. Li C, Paris O, Siegel S, Roschger P, Paschali EP, Klaushofer, Fratzl KP (2009) Strontium is incorporated into mineral crystals only in newly formed bone during strontium ranelate treatment. JBMR [epub ached of printing]

Download references

Author information

Authors and Affiliations

  1. The National Research Center for Endocrinology, Moscow, Russia

    Zhanna E. Belaya

Authors
  1. Zhanna E. Belaya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhanna E. Belaya.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Belaya, Z.E. Should we really compare absolute risk reduction in different trials on osteoporosis: comment on the article by Ringe JD and Doherty JG. Rheumatol Int 31, 1669–1671 (2011). https://doi.org/10.1007/s00296-010-1626-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-010-1626-8

Keywords

Search

Navigation